SGX Google Yahoo TradingView

IX BIOPHARMA LTD. (42C) SGD 0.355   -1.41% -0.01

Portfolio Watchlist
Moomoo 12 days ago
IX Biopharma Allots, Issues New Shares
Moomoo 22 days ago
IX Biopharma Allots, Issues More Shares
Moomoo 23 days ago
IX Biopharma Narrows Loss in Fiscal Q3
TipRanks a month ago
iX Biopharma Wins Conditional SGX Nod for New Share Placement
world.infonasional.com a month ago
IX Biopharma Aims to Lead Non-Opioid Pain Relief with Wafermine
The Business Times a month ago
Singapore-listed IX Biopharma bets big on non-opioid pain relief
The Edge Singapore a month ago
PhillipCapital re-initiates coverage on iX Biopharma with target price of $1
Yahoo Finance Singapore a month ago
iX Biopharma issues 10 mil new ordinary shares at exercise price of six cents each
Yahoo Finance Singapore a month ago
iX Biopharma's executive chairman injects $600,000 into company via exercise of warrants
Yahoo Finance Singapore 2 months ago
Forget 2.5%: These 5 SGX Stocks Pay Double Your CPF OA
Singapore Business Review 3 months ago
iX Biopharma gets SGX nod to list 75.8 million shares in $6m placement
Yahoo Finance Singapore 3 months ago
Budget 2026 Injects Another S$1.5 Billion Into SGX. Are Singapore Mid-Cap Stocks About to Surge?
Singapore Business Review 3 months ago
iX Biopharma narrows losses in H1 FY 2026 despite 14% fall in revenue
The Edge Singapore 3 months ago
iX Biopharma reports lower net loss for 1HFY2026
Yahoo Finance Singapore 3 months ago
3 Singapore Stocks to Watch in the Week of 9 February 2026
Yahoo Finance Singapore 4 months ago
3 Blue Chip Stocks That Could Benefit if SGX Reduces Board Lot Size
The Straits Times 4 months ago
Drug delivery patent fuels iX Biopharma's growth
Yahoo Finance Singapore 4 months ago
Top Stock Market Highlights of the Week: SGX-Nasdaq Dual Listing Bridge, Centurion Accommodation REIT, and CICT’s Portfolio Moves
Yahoo Finance Singapore 5 months ago
Former GIC and Avanda's Sung Cheng Chih to be new chairman of SGX RegCo
Minichart 5 months ago
2025: A Breakout Year for Singapore’s Capital Markets Beyond the STI

© 2026 Dividends.sg